vTv Therapeutics Inc. (VTVT) stock
VTVTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3062% below fair value
$17.29−0.40 (-2.26%)
Close on Nov 17, 2026Market cap $68.37MP/E –Yield –
vTv Therapeutics gross margin
Gross margin is gross profit as a percentage of revenue.
No gross margin figures for vTv Therapeutics
vTv Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?